Checkpoint Inhibition in Stage III NSCLC: Current Practice, Open Questions, and Future Directions

Download the slidesets and watch an on-demand Webcast from our satellite symposium at SITC 2018 where expert faculty shared their perspectives on the use of checkpoint inhibitors in the treatment of unresectable stage III NSCLC including review of the latest clinical data and case discussions on the subtleties and challenges of their optimal application in this earlier disease setting.

Share

Program Content

Activities

ICI in Stage III NSCLC: Current Practice
Current Practice: Checkpoint Inhibitors in Unresectable Stage III NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2018

Expires: November 07, 2019

ICI in Stage III NSCLC: Case Discussions
Open Questions: Case Discussions on Optimal Integration of Checkpoint Inhibitors into the Management of Unresectable Stage III NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2018

Expires: November 07, 2019

ICI in Stage III NSCLC: Future Directions
Future Directions: Moving Checkpoint Inhibitors into Earlier NSCLC Settings
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2018

Expires: November 07, 2019

Activities

Expert Advice on ICIs for Stage III NSCLC
Checkpoint Inhibition in Stage III NSCLC: Current Practice, Open Questions, and Future Directions
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 02, 2019

Expires: January 01, 2020

Faculty

cover img faculity

Julie Brahmer, MD

Associate Professor of Oncology
Oncology/Upper Aerodigestive Cancer Program
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

cover img faculity

Edward B. Garon, MD, MS

Professor of Medicine
Director of Thoracic Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Naiyer Rizvi, MD

Professor of Medicine
Price Chair of Thoracic Translational Oncology

Director of Thoracic Oncology
Director of Immuno-Oncology
Columbia University Medical Center
New York, New York

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

AstraZeneca